Abstract:Abstract Mutations in the pituitary specific transcription factor Prophet of Pit-1 (PROP1) are the most common genetic etiology of combined pituitary hormone deficiency (CPHD), which affects 1 in 8,000 newborns worldwide. CPHD is associated with short stature, attributable to growth hormone (GH) deficiency and/or thyroid stimulating hormone (TSH) deficiency. Pathogenic lesions impair pituitary development and differentiation of endocrine cells. Prop1-mutant mice show increased expression of genes including SRY-Box Transcription Factor 21 (Sox21) and Pou Domain, Class 3, Transcription Factor 4 (Pou3f4). POU3F4 is expressed in the developing inner ear and restricts the proliferation and lineage potential of neural stem cells. Genetic defects cause non-syndromic X-linked deafness (DFNX2) in humans and mice. The function of POU3F4 in pituitary development is largely unknown and the implications of its overexpression in Prop1-mutant pituitaries remain unexplored. Therefore, we aim to address the role of Pou3f4 in pituitary development and determine the contributions of Pou3f4 upregulation to pituitary disease by utilizing Pou3f4-mutant mice as well as double mutant mice lacking both Prop1 and Pou3f4. Utilizing immunofluorescent analysis at critical timepoints during pituitary development, we have characterized the timeline for endogenous POU3F4 expression. Initial expression is detected at e11.5 in differentiating cells on the ventral side of Rathke's pouch and is restricted to the proliferating anterior lobe at e13.5, continuing postnatally, similar to previously published expression data. POU3F4 expression then decreases and becomes gradually restricted to the periluminal stem cell niche at e15.5 and p0. We further validated the upregulation of POU3F4 in histological sections of Prop1-mutant mice at e15 and p0, finding increased expression in the developing anterior lobe of mutants compared to wildtypes. Single-cell regulatory network inference and clustering (SCENIC) analyses, which utilize single-cell transcription factor co-expression with potential direct downstream targets that contain the corresponding transcription factors’ binding sequence to infer active transcription networks, predict increased activity of the Pou3f4 gene regulatory network in a subpopulation of Sox2-expressing stem cells in Prop1-mutant mice. Preliminary analyses indicate that Pou3f4 mutant have normal morphology at P1, together with grossly normal expression of Sox2 and Pou1f1. We are performing quantitative PCR to determine possible compensatory mechanisms in response to loss of Pou3f4 expression. To investigate whether any Prop1-mutant phenotypes, including dysmorphology and ectopic expression of Sox21 and Otog, are attributable to Pou3f4 upregulation, we are studying Pou3f4;Prop1 mice. We will determine the impacts of POU3F4 upregulation on cellular morphology, stem cell maintenance and endocrine cell differentiation. The mechanisms of action in the regulation of stem cell differentiation constitutes a gap in our current understanding of the pathogenesis of CPHD. These studies will provide novel insights into the mechanistic function of Pou3f4 during embryonic pituitary development and potential novel etiologies of CPHD in human patients. Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.

Gene Misexpression in a Smoc2+ve/ Sox2-Low Population in Juvenile Prop1-Mutant Pituitary Gland

PMON145 The Role of Pou3f4 in Pituitary Development and Disease

Comparative genomics reveals functional transcriptional control sequences in the Prop1 gene

Temporal Analysis of Pituitary Transcriptional Dynamics in Mice Models of Hypopituitarism During Postnatal Development

FOXL2C134W-Induced CYP19 Expression via Cooperation With SMAD3 in HGrC1 Cells

Pit-1-Dependent Expression Of The Receptor For Growth-Hormone Releasing-Factor Mediates Pituitary Cell-Growth

Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion

Pituitary Lineage Determination by the Prophet of Pit-1 Homeodomain Factor Defective in Ames Dwarfism

A large deletion of PROP1 gene in patients with combined pituitary hormone deficiency from two unrelated Chinese pedigrees.

Comparison of clinical characteristics of a pediatric cohort with combined pituitary hormone deficiency caused by mutation of the PROP1 gene or of other origins

Increased Transactivation and Impaired Repression of Β-Catenin-mediated Transcription Associated with a Novel SOX3 Missense Mutation in an X-linked Hypopituitarism Pedigree with Modest Growth Failure.

[Clinical and Genetic Characteristics of a Young Child with Combined Pituitary Hormone Deficiency Type I Caused by POU1F1 Gene Variation].

Pituitary Ontogeny of the Snell Dwarf Mouse Reveals Pit-1-independent and Pit-1-dependent Origins of the Thyrotrope

Effect of Transcription Factor ZBTB20 on Mouse Pituitary Development.

Interplay between Pitx2 and Pax7 temporally governs specification of extraocular muscle stem cells

Compound Heterozygous Mutations in SMO Associated with Anterior Segment Dysgenesis and Morning Glory Syndrome

Divergent roles of SOX2 in human and mouse germ cell specification related to X-linked gene dosage effects

A Tissue-Specific Enhancer Confers Pit-1-dependent Morphogen Inducibility and Autoregulation on the Pit-1 Gene.

Restricted Growth and Insulin-Like Growth Factor-1 Deficiency in Mice Lacking Presenilin-1 in the Neural Crest Cell Lineage

Major depletion of SOX2+ stem cells in the adult pituitary is not restored which does not affect hormonal cell homeostasis and remodelling

Molecular Basis of the Little Mouse Phenotype and Implications for Cell Type-Specific Growth